Sign in
4

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0001724521-23-000064

Chief Executive Officer returned 27,705 shares (to the company)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROSEN TERRY J · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-12-18 Returned to the company : show line 1 in the form 10b5-1 −13,705 $17.74 $243,127 3,880,526 D
2023-12-19 Returned to the company : show line 2 in the form 10b5-1 −14,000 $18.09 $253,260 3,866,526 D
Loading xslF345X05/wk-form4_1703106555.xml…